Regeneron Pharmaceuticals Inc (REGN) — Financial Flexibility Index
Regeneron Pharmaceuticals Inc (REGN) has a Financial Flexibility Index of 0.08x as of June 2026. Free cash flow of $814.70 Million (operating CF $574.50 Million minus capex $240.20 Million) represents 0% of total liabilities ($10.02 Billion). Check cash flow reinvestment rate of Regeneron Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Regeneron Pharmaceuticals Inc Financial Flexibility Index (1991–2025)
Historical Financial Flexibility Index trend for Regeneron Pharmaceuticals Inc across 35 annual periods. For the full cash flow conversion analysis, see Regeneron Pharmaceuticals Inc cash flow conversion.
Annual Financial Flexibility Index for Regeneron Pharmaceuticals Inc (1991–2025)
Year-by-year free cash flow to debt coverage for Regeneron Pharmaceuticals Inc. Explore cash flow to debt ratio of Regeneron Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | $5.88 Billion | $4.98 Billion | $9.30 Billion | ▲ +2.6% |
| 2024 | 0.62x | $5.18 Billion | $4.42 Billion | $8.41 Billion | ▼ -20.7% |
| 2023 | 0.78x | $5.52 Billion | $4.59 Billion | $7.11 Billion | ▼ -9.2% |
| 2022 | 0.86x | $5.61 Billion | $5.01 Billion | $6.55 Billion | ▼ -25.3% |
| 2021 | 1.15x | $7.63 Billion | $7.08 Billion | $6.67 Billion | ▲ +117.4% |
| 2020 | 0.53x | $3.23 Billion | $2.62 Billion | $6.14 Billion | ▼ -31.6% |
| 2019 | 0.77x | $2.86 Billion | $2.43 Billion | $3.72 Billion | ▼ -11.1% |
| 2018 | 0.87x | $2.58 Billion | $2.20 Billion | $2.98 Billion | ▲ +43.6% |
| 2017 | 0.60x | $1.58 Billion | $1.31 Billion | $2.62 Billion | ▼ -23.8% |
| 2016 | 0.79x | $2.00 Billion | $1.49 Billion | $2.52 Billion | ▼ -23.0% |
| 2015 | 1.03x | $2.01 Billion | $1.33 Billion | $1.95 Billion | ▲ +25.9% |
| 2014 | 0.82x | $1.09 Billion | $752.43 Million | $1.33 Billion | ▲ +9.5% |
| 2013 | 0.75x | $744.92 Million | $588.60 Million | $998.94 Million | ▲ +2563.6% |
| 2012 | -0.03x | $-25.28 Million | $-74.61 Million | $835.11 Million | ▲ +70.0% |
| 2011 | -0.10x | $-84.47 Million | $-141.68 Million | $837.85 Million | ▼ -128.9% |
| 2010 | 0.35x | $196.03 Million | $96.34 Million | $561.62 Million | ▲ +379.2% |
| 2009 | 0.07x | $25.09 Million | $-72.23 Million | $344.44 Million | ▲ +133.7% |
| 2008 | -0.22x | $-54.23 Million | $-89.09 Million | $251.19 Million | ▼ -324.3% |
| 2007 | 0.10x | $45.82 Million | $27.37 Million | $475.99 Million | ▲ +37.0% |
| 2006 | 0.07x | $25.89 Million | $23.07 Million | $368.47 Million | ▲ +185.8% |
| 2005 | -0.08x | $-25.33 Million | $-30.30 Million | $309.50 Million | ▼ -121.5% |
| 2004 | -0.04x | $-10.73 Million | $-16.91 Million | $290.56 Million | ▼ -153.7% |
| 2003 | 0.07x | $23.52 Million | $-6.13 Million | $341.91 Million | ▲ +122.2% |
| 2002 | -0.31x | $-76.15 Million | $-110.52 Million | $245.59 Million | ▼ -44.7% |
| 2001 | -0.21x | $-49.10 Million | $-57.32 Million | $229.04 Million | ▲ +73.8% |
| 2000 | -0.82x | $-21.41 Million | $-27.91 Million | $26.14 Million | ▼ -178.1% |
| 1999 | -0.29x | $-8.10 Million | $-13.80 Million | $27.50 Million | ▼ -5.1% |
| 1998 | -0.28x | $-7.20 Million | $-10.20 Million | $25.70 Million | ▼ -106.6% |
| 1997 | -0.14x | $-4.00 Million | $-6.10 Million | $29.50 Million | ▲ +64.4% |
| 1996 | -0.38x | $-11.70 Million | $-20.30 Million | $30.70 Million | ▲ +33.8% |
| 1995 | -0.58x | $-14.90 Million | $-18.20 Million | $25.90 Million | ▼ -14.6% |
| 1994 | -0.50x | $-13.60 Million | $-20.50 Million | $27.10 Million | ▲ +51.6% |
| 1993 | -1.04x | $-19.90 Million | $-30.10 Million | $19.20 Million | ▲ +26.6% |
| 1992 | -1.41x | $-15.10 Million | $-17.20 Million | $10.70 Million | ▼ -89.8% |
| 1991 | -0.74x | $-5.80 Million | $-6.80 Million | $7.80 Million | — |